Vimarsana
Biggest News Aggregation in the World

Page 3 - Param Desai News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Param Desai. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Param Desai Today - Breaking & Trending Today

World News | Huge Car Rally Planned in California to Celebrate Ram Mandir Consecration in Ayodhya - Vimarsana News

World News | Huge Car Rally Planned in California to Celebrate Ram Mandir Consecration in Ayodhya

Get latest articles and stories on World at LatestLY. The Indian-American diaspora is gearing up to commemorate the consecration ceremony of the Ram Mandir in Ayodhya, with plans to hold car rallies in the US to celebrate the occasion. World News | Huge Car Rally Planned in California to Celebrate Ram Mandir Consecration in Ayodhya.

How Aster DM's GCC separation deal will spur its growth in Indian market, analysts say - Vimarsana News

How Aster DM's GCC separation deal will spur its growth in Indian market, analysts say

After the separation, the India and GCC entities will operate under dedicated management teams

pharma stocks to buy: Param Desai's 4 top picks in largecap and midcap pharma - Vimarsana News

pharma stocks to buy: Param Desai's 4 top picks in largecap and midcap pharma

“We believe that Ciplas Pithampur facility was inspected in February and post that, they got an OAI in August and post that, it has escalated to a warning letter. We believe that it is unlikely that this will escalate further to import alerts, though this may take some time to resolve.”

US sales momentum, margin gains to support pharma major Cipla's stock - Vimarsana News

US sales momentum, margin gains to support pharma major Cipla's stock

A strong performance in the July-September quarter of 2023-24 (Q2FY24), an upward revision in the margin guidance and sustained momentum in US sales has helped the stock of pharmaceutical major Cipla gain about 2 per cent over the last two trading sessions. The brokerages have upgraded the earnings estimates for this financial year (FY24) by 6-9 per cent to factor in the improved margin guidance and sales in the US market. Led by the US market, which rose by 31 per cent, the company posted a 16 per cent growth in revenues.

Source: rediff.com
Strong profit growth keeps brokerages positive on Torrent - Vimarsana News

Strong profit growth keeps brokerages positive on Torrent

Even as the broader markets were under pressure, the stock of Torrent Pharmaceuticals was down 1.05 per cent on October 26. This was on expectation that steady sales growth momentum in core markets such as India and Brazil and recovery in the US market coupled with margin expansion will drive strong earnings growth over the next couple of years. Brokerages are working with the net profit growth of 28-34 per cent annually over the FY23-25 period.

Source: rediff.com